UCI President Backs Night-Time Drug Testing After Tour de France 2026

The UCI president David Lappartient has backed night-time drug testing in cycling after the Tour de France controversy, emphasizing that while such tests are exceptional, they are a necessary tool in the fight against doping. In a recent statement, Lappartient addressed the ongoing suspicion that plagues the sport, noting that the absence of positive test announcements from the International Testing Agency (ITA) indicates a clean race.

UCI President Defends Night-Time Testing as a Strategic Tool

Lappartient, speaking at the start of stage two of the Tour de France Femmes in Aigle, supported the ITA's use of night-time tests in specific cases. He explained that micro-dosing EPO can evade detection within six to seven hours, making unannounced late-night or early-morning tests crucial. "We support the ITA if they have to do some specific test," he said, adding that the possibility of a night visit creates a deterrent effect among riders.

However, he stressed that such testing should not become routine. "We will not support something they do every night on the riders. The normal hours [of testing] are not in the night," Lappartient clarified. He emphasized that night testing must be used "very exceptionally" and as part of a broader anti-doping strategy, not as a daily intrusion.

The Tour de France Controversy and the ITA's Role

This year's men's Tour de France saw top contenders Tadej Pogacar and Jonas Vingegaard subjected to night-time tests at 5am and 2am respectively. The ITA's actions sparked debate, but Lappartient defended the approach, noting that the lack of positive results suggests the race was clean. "The ITA never make a press release about negative results, only about positive results," he said, adding that no press releases meant no doping violations.

Lappartient, who is also an International Olympic Committee member, believes that transparency and stakeholder involvement are key to reforming sports governance. He drew parallels to his own leadership at the UCI, stating, "I will not interfere in Fifa's matters, but I can tell you that in the UCI transparency is important."

Comparing Night-Time Testing vs. Standard Testing

Key Takeaways from the UCI President's Stance

• Night-time testing is supported as an exceptional measure, not a routine practice.
• The ITA's lack of positive results at the Tour de France indicates a clean race.
• Micro-dosing EPO requires testing within hours, making night-time checks valuable.
• Lappartient emphasizes transparency and stakeholder involvement in sports governance.
• Riders should expect occasional unannounced tests to maintain credibility.

What This Means for Cycling's Future

Lappartient's comments signal a balanced approach: using night-time testing strategically while respecting athletes' well-being. The UCI's collaboration with the ITA is likely to continue, with more targeted tests during major races. This could enhance the sport's integrity without overburdening riders.

For fans, the message is clear: cycling is committed to clean competition, and the UCI will adapt its methods to stay ahead of dopers. As Lappartient noted, "We always have suspicion in cycling, due to our past," but proactive measures like night-time testing are steps toward rebuilding trust.

FAQ